Overview

Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients

Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
This study will assess the efficacy of multiple-dose of STSP-0601 for the treatment of bleeding episodes in hemophilia A or B patients with inhibitor
Phase:
PHASE3
Details
Lead Sponsor:
Jiangsu BioJeTay Biotechnology Co., Ltd.
Treatments:
Injections